DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Busse WW, Holgate S, Kerwin E. , et al.
Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma.
Am J Respir Crit Care Med 2013;
188 (11) 1294-1302
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.